Literature DB >> 28418447

Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.

Amy Anne D Lassig1, Anne M Joseph2, Bruce R Lindgren3, Bevan Yueh4.   

Abstract

Importance: Survival rates for head and neck cancer have been relatively stable for several decades. Individualized prognostic indicators are needed to identify patients at risk for poorer outcomes. Objective: To determine whether biomarker levels in surgical drain fluid of patients with head and neck cancer are associated with poor cancer outcomes. Design, Setting, and Participants: This prospective cohort study enrolled patients with squamous cell carcinoma (SCC) of the oral cavity and oropharynx who required surgical treatment from April 1, 2011, to February 1, 2016, at a tertiary or academic care center. Twenty patients, including 14 with stage IV disease, had complete specimen collection. Differences in cytokine and MMP levels by disease outcomes were evaluated. Interventions: Patients underwent surgical treatment with drain placement as dictated by the standard of care. Drain fluid samples were collected every 8 hours postoperatively until drains were removed because of clinical criteria. Levels of cytokines and matrix metalloproteinases (MMPs) were measured using electrochemiluminescent, patterned array, multiplex technology. Main Outcomes and Measures: The primary clinical outcome measures were survival outcome and recurrence. The biomarkers measured included the cytokines basic fibroblastic growth factor, vascular endothelial growth factor isoform A, soluble fms-like tyrosine kinase-1 (sFlt-1), and placental growth factor (PIGF) and MMP-1, MMP-3, and MMP-9. Other clinical and pathologic cancer characteristics were recorded.
Results: In this cohort of 20 patients with SCC (15 men and 5 women; mean [SD] age, 63.5 [9.9] years), a significant association with recurrence was found for levels of MMP-1 (relative difference between groups, 2.78; 95% CI, 1.23-6.29), MMP-3 (relative difference between groups, 5.29; 95% CI, 2.14-13.05), and sFlt-1 (relative difference between groups, 3.75; 95% CI, 1.84-7.65). No biomarkers were associated with disease outcome. Vascular endothelial growth factor isoform A was associated with nodal metastasis (relative difference between groups, 1.98; 95% CI, 1.12-3.51), and basic fibroblastic growth factor was associated with lymphovascular invasion (relative difference between groups, 1.74; 95% CI, 1.02-2.97). Conclusions and Relevance: In this pilot sample of patients with SCC of the oral cavity and oropharynx, MMP-1, MMP-3, and sFlt-1 levels in wound fluid were associated with poor clinical cancer outcomes in the form of recurrence. This finding is consistent with the literature of tumor microenvironment in saliva, serum, and tumor tissue biomarkers. To our knowledge, this report is the first of such findings in surgical drain fluid, an easily accessible means of cytokine measurement. Measurement of these biomarkers in surgical fluid potentially represents a novel means of assessing cancer prognosis in this population.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28418447      PMCID: PMC5824201          DOI: 10.1001/jamaoto.2016.3595

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  40 in total

1.  Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.

Authors:  Marni Stott-Miller; John R Houck; Pawadee Lohavanichbutr; Eduardo Méndez; Melissa P Upton; Neal D Futran; Stephen M Schwartz; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

2.  Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.

Authors:  Faina Linkov; Alex Lisovich; Zoya Yurkovetsky; Adele Marrangoni; Lyudmila Velikokhatnaya; Brian Nolen; Matthew Winans; William Bigbee; Jill Siegfried; Anna Lokshin; Robert L Ferris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01       Impact factor: 4.254

3.  Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma.

Authors:  J J Homer; J Greenman; N D Stafford
Journal:  Clin Otolaryngol Allied Sci       Date:  2002-02

4.  Early Modification in Drainage of Interleukin-1β and Tumor Necrosis Factor-α Best Predicts Surgical-Site Infection After Cervical Neck Dissection for Oral Cancer.

Authors:  Alberto Candau-Alvarez; Mercedes Gil-Campos; Maria Jose De la Torre-Aguilar; Francisco Llorente-Cantarero; Jose Lopez-Miranda; Juan Luis Perez-Navero
Journal:  J Oral Maxillofac Surg       Date:  2015-01-06       Impact factor: 1.895

5.  Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma.

Authors:  Maryam Elahi; Vahid Rakhshan; Nasim Taghavi Ghasemian; Mohamad Moshref
Journal:  Biomarkers       Date:  2011-11-22       Impact factor: 2.658

6.  Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy.

Authors:  A Dietz; V Rudat; C Conradt; H Weidauer; A Ho; T Moehler
Journal:  Head Neck       Date:  2000-10       Impact factor: 3.147

7.  VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.

Authors:  Alexander Schultze; Isabel Ben Batalla; Sabine Riethdorf; Michael Bubenheim; Emre Yekebas; Andreas Erbersdobler; Uta Reichelt; Katharina E Effenberger; Thomas Schmidt; Jakob R Izbicki; Carsten Bokemeyer; Klaus Pantel; Walter Fiedler; Sonja Loges
Journal:  Clin Exp Metastasis       Date:  2012-04-08       Impact factor: 5.150

8.  Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer.

Authors:  C Kuropkat; S Plehn; U Herz; A A Dünne; H Renz; J A Werner
Journal:  Anticancer Res       Date:  2002 Jul-Aug       Impact factor: 2.480

9.  Expression of matrix metalloproteinase-9 in patients with squamous cell carcinoma of the larynx.

Authors:  Zavisa Colović; Valdi Pesutić-Pisac; Nikola Kolja Poljak; Goran Racić; Drasko Cikojević; Mirko Kontić
Journal:  Coll Antropol       Date:  2013-03

10.  Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis.

Authors:  Meilan Chen; Erhui Cai; Jizheng Huang; Ping Yu; Ke Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

View more
  6 in total

1.  Addition to Funding/Support.

Authors: 
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-02-01       Impact factor: 6.223

2.  Changes in oncogenic protein levels in peri-implant oral malignancy: a case report.

Authors:  Mi Hyun Seo; Hoon Myoung; Jong Ho Lee; Soung Min Kim; Suk Keun Lee
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-11-08

3.  Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.

Authors:  Kotaro Ito; Yoshihiko Kitajima; Keita Kai; Shohei Matsufuji; Kohei Yamada; Noriyuki Egawa; Hiroshi Kitagawa; Keiichiro Okuyama; Tomokazu Tanaka; Hirokazu Noshiro
Journal:  Int J Oncol       Date:  2021-11-05       Impact factor: 5.650

4.  ALK-rearranged lung adenocarcinoma resistant to alectinib with cauliflower gingival metastasis responds to brigatinib.

Authors:  Lianxi Song; Liang Zeng; Yongchang Zhang
Journal:  Thorac Cancer       Date:  2022-02-11       Impact factor: 3.500

Review 5.  Wound fluid sampling methods for proteomic studies: A scoping review.

Authors:  Joe Harvey; Kieran T Mellody; Nicky Cullum; Rachel E B Watson; Jo Dumville
Journal:  Wound Repair Regen       Date:  2022-04-05       Impact factor: 3.401

Review 6.  A Systematic Review of Oral Biopsies, Sample Types, and Detection Techniques Applied in Relation to Oral Cancer Detection.

Authors:  Guanghuan Yang; Luqi Wei; Benjamin K S Thong; Yuanyuan Fu; Io Hong Cheong; Zisis Kozlakidis; Xue Li; Hui Wang; Xiaoguang Li
Journal:  BioTech (Basel)       Date:  2022-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.